LetterLetter
Consider Using Diffusion Tensor Imaging in Geron Phase I Trial
C.B. Patel
American Journal of Neuroradiology August 2009, 30 (7) e97; DOI: https://doi.org/10.3174/ajnr.A1632
References
- ↵Couzin J. Biotechnology: celebration and concern over U.S. trial of embryonic stem cells. Science 2009;323:568
- ↵Geron Corporation. Geron receives FDA clearance to begin world’s first human clinical trial of embryonic stem cell-based therapy. Available at: http://geron.com/grnopc1clearance/grnopc1-backgrounder.pdf. Accessed February 5,2009
- ↵
- ↵Budde MT, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Res Med 2007;57:688–95
- ↵Mori S, Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006;51:527–39
- ↵Féron F, Perry C, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 2005;128:2951–60
In this issue
Advertisement
Consider Using Diffusion Tensor Imaging in Geron Phase I Trial
C.B. Patel
American Journal of Neuroradiology Aug 2009, 30 (7) e97; DOI: 10.3174/ajnr.A1632
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement